Having co-developed the power electronics behind ORNL’s compact, high-level wireless power technology for automobiles, Erdem Asa is looking to the skies to apply the same breakthrough to aviation.
When Hope Corsair’s new colleagues at Oak Ridge National Laboratory ask her about her area of expertise, she tells them it’s “context.” Her goal as an energy economist is to make sure ORNL’s breakthroughs have the widest possible
Four first-of-a-kind 3D-printed fuel assembly brackets, produced at the Department of Energy’s Manufacturing Demonstration Facility at Oak Ridge National Laboratory, have been installed and are now under routine operating
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
RamSat’s mission is to take pictures of the forests around Gatlinburg, which were destroyed by wildfire in 2016. The mission is wholly designed and carried out by students, teachers and mentors, with support from numerous organizations, including Oak Ridge National Laboratory.
As a computer engineer at Oak Ridge National Laboratory, Gina Accawi has long been the quiet and steady force behind some of the Department of Energy’s most widely used online tools and applications.
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
In his career focused on energy storage science, Jianlin Li has learned that discovering new ways to process and assemble batteries is just as important as the development of new materials.
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.